A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase 2a, multinational, multicenter, double‐blind, randomized,placebo‐controlled, dose‐ranging safety, tolerability and PK study in patients with HABP(Hospital Acquired Bacterial Pneumonia) or VABP (Ventilator Associated BacterialPneumonia) caused by ABC to identify safe and well‐tolerated doses and to assess the PKprofile of OMN6 in patients.
Epistemonikos ID: 801ea783e69ccd7891885c3ce3bbd96262b6d556
First added on: May 15, 2024